← Oncology Approval Tracker

FDA DECISION ·

Idelalisib tablets

idelalisib · Natco Pharma

First generic approvalFirst genericCLL / SLL
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic of Zydelig tablets with rituximab for relapsed CLL in patients for whom comorbidities make rituximab alone an appropriate option.

LAMPGEN ANALYSIS

Why it matters

This generic action applies to a defined relapsed CLL population. The comorbidity criterion matters when explaining how the combination is used.

What research teams should watch

Check the reference and generic label for the selected use and confirm pharmacy availability. Maintain monitoring for the established regimen’s safety risks.

PRIMARY RECORDS

Sources